Eli Lilly and Insilico Medicine forge $2.75bn AI-driven R&D pact
Eli Lilly is joining forces with artificial intelligence (AI)-powered biotech, Insilico Medicine, in a drug discovery and development…
Eli Lilly-backed Insilico eyes beyond pharma with new AI models
Interview Biotech company shares jumped 46% in $300m Hong Kong debut Biotech firm Insilico Medicine leverages artificial intelligence…